We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current AKZA market cap is 9.53B. The company's latest EPS is EUR 2.5909 and P/E is 21.55.
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Total Revenue | 9.28B | 8.53B | 9.59B | 10.85B | 10.67B |
Operating Income | 861M | 988M | 1.14B | 726M | 1.06B |
Net Income | 539M | 630M | 829M | 352M | 442M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Total Assets | 12.98B | 13.18B | 13.88B | 14.74B | 14.56B |
Total Liabilities | 6.42B | 7.23B | 8.24B | 10.19B | 10.01B |
Total Equity | 6.57B | 5.95B | 5.64B | 4.55B | 4.55B |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Operating | 23M | 1.22B | 605M | 263M | 1.13B |
Investing | 5.01B | -427M | -134M | -1.1B | -144M |
Financing | -6.58B | -353M | -974M | 1.14B | -827M |
Market Cap | 9.53B |
Price to Earnings Ratio | 21.55 |
Price to Sales Ratio | 0.89 |
Price to Cash Ratio | 6.54 |
Price to Book Ratio | 2.1 |
Dividend Yield | - |
Shares Outstanding | 170.6M |
Average Volume (1 week) | 405.67k |
Average Volume (1 Month) | 428.44k |
52 Week Change | -25.47% |
52 Week High | 75.30 |
52 Week Low | 52.82 |
Spread (Intraday) | 1 (1.77%) |
Company Name | Akzo Nobel NV |
Address |
christian neefestraat 2 amsterdam, north holland 1070 AS |
Website | https://www.akzonobel.com |
Industry | health care diversified (H) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions